Grifols Expands its PatientCare Program to Address Insurance Lapses in the Primary Immune Deficiency Community
Grifols, Inc. today announced that it has expanded the company’s PatientCare Program to offer immune globulins (IVIG) to the Primary Immune Deficiency community (PID). The program will provide Flebogamma® 5% DIF (Immune Globulin Intravenous (Human)) or Flebogamma® 10% DIF (Immune Globulin Intravenous (Human)) at no cost to patients with PID when insurance coverage is not [...]